[
  {
    "ts": null,
    "headline": "S&P 500 Gains and Losses Today: Nvidia Leads Chip, AI Stocks Lower",
    "summary": "The S&P 500 fell 1.6% on Thursday, Feb. 27, as Nvidia led semiconductor and AI stocks lower and investors digested President Trump's latest announcement on tariffs.",
    "url": "https://finnhub.io/api/news?id=21cc83bf83e3d7f1e781f889271a2d12c046f508879adcdbcb8409f5225b9afe",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1740691996,
      "headline": "S&P 500 Gains and Losses Today: Nvidia Leads Chip, AI Stocks Lower",
      "id": 133193531,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "VTRS",
      "source": "Yahoo",
      "summary": "The S&P 500 fell 1.6% on Thursday, Feb. 27, as Nvidia led semiconductor and AI stocks lower and investors digested President Trump's latest announcement on tariffs.",
      "url": "https://finnhub.io/api/news?id=21cc83bf83e3d7f1e781f889271a2d12c046f508879adcdbcb8409f5225b9afe"
    }
  },
  {
    "ts": null,
    "headline": "Why Viatris (VTRS) Shares Are Falling Today",
    "summary": "Shares of medication company Viatris (NASDAQ:VTRS) fell 16.9% in the morning session after the company reported disappointing fourth-quarter 2024 results, with sales, earnings, and operating income all missing analysts' expectations. Sales came in soft, driven by strength in Greater China and new product launches, but weighed down by weaker performance in Developed and Emerging Markets​. Looking ahead, Viatris' 2025 guidance also disappointed, with revenue and adjusted EBITDA projections falling",
    "url": "https://finnhub.io/api/news?id=c24aaf4f93f598592796fb5dc50a247174fc09ef638c6480583e1c1d13770f76",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1740686797,
      "headline": "Why Viatris (VTRS) Shares Are Falling Today",
      "id": 133193532,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "VTRS",
      "source": "Yahoo",
      "summary": "Shares of medication company Viatris (NASDAQ:VTRS) fell 16.9% in the morning session after the company reported disappointing fourth-quarter 2024 results, with sales, earnings, and operating income all missing analysts' expectations. Sales came in soft, driven by strength in Greater China and new product launches, but weighed down by weaker performance in Developed and Emerging Markets​. Looking ahead, Viatris' 2025 guidance also disappointed, with revenue and adjusted EBITDA projections falling",
      "url": "https://finnhub.io/api/news?id=c24aaf4f93f598592796fb5dc50a247174fc09ef638c6480583e1c1d13770f76"
    }
  },
  {
    "ts": null,
    "headline": "Viatris Q4 Earnings and Revenues Miss Estimates, Stock Plunges",
    "summary": "VTRS Q4 earnings and sales miss estimates. The guidance for 2025 looks disappointing due to the financial impact of the Indore facility warning letter and import alert. Stock down.",
    "url": "https://finnhub.io/api/news?id=fc15ade6dc3aa68bb37f5311370a902ead309535453a4ac00472ef836d530063",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1740682560,
      "headline": "Viatris Q4 Earnings and Revenues Miss Estimates, Stock Plunges",
      "id": 133193533,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "VTRS",
      "source": "Yahoo",
      "summary": "VTRS Q4 earnings and sales miss estimates. The guidance for 2025 looks disappointing due to the financial impact of the Indore facility warning letter and import alert. Stock down.",
      "url": "https://finnhub.io/api/news?id=fc15ade6dc3aa68bb37f5311370a902ead309535453a4ac00472ef836d530063"
    }
  },
  {
    "ts": null,
    "headline": "eBay, Rolls-Royce, Viatris: Market Minute",
    "summary": "Yahoo Finance anchor Brad Smith takes a closer look at the top stories affecting the market in today's Market Minute. eBay (EBAY) shares fall after its first quarter outlook fell short of expectations. Rolls-Royce Holdings (RYCEY) stock pops after the company issued stronger-than-expected guidance. Shares of Viatris (VTRS) plunge after its 2025 outlook disappointed investors. Stay up to date on the latest market action, minute-by-minute, with Yahoo Finance's Market Minute. This post was written by Naomi Buchanan.",
    "url": "https://finnhub.io/api/news?id=7b266cc1f56b0d083d8b188e4bfd67d8fb772035faca14861bc123228883bee9",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1740680851,
      "headline": "eBay, Rolls-Royce, Viatris: Market Minute",
      "id": 133181380,
      "image": "https://s.yimg.com/ny/api/res/1.2/.hhBfyMNB8N_opFCY.E9Gw--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD02NzQ-/https://s.yimg.com/os/creatr-uploaded-images/2025-02/73e7c430-f537-11ef-bfbf-8ad159511ea5",
      "related": "VTRS",
      "source": "Yahoo",
      "summary": "Yahoo Finance anchor Brad Smith takes a closer look at the top stories affecting the market in today's Market Minute. eBay (EBAY) shares fall after its first quarter outlook fell short of expectations. Rolls-Royce Holdings (RYCEY) stock pops after the company issued stronger-than-expected guidance. Shares of Viatris (VTRS) plunge after its 2025 outlook disappointed investors. Stay up to date on the latest market action, minute-by-minute, with Yahoo Finance's Market Minute. This post was written by Naomi Buchanan.",
      "url": "https://finnhub.io/api/news?id=7b266cc1f56b0d083d8b188e4bfd67d8fb772035faca14861bc123228883bee9"
    }
  },
  {
    "ts": null,
    "headline": "Viatris Inc. stock falls Thursday, underperforms market",
    "summary": "Viatris Inc. stock falls Thursday, underperforms market",
    "url": "https://finnhub.io/api/news?id=6b578044d9a6ea461832329531e8c1452bae5835ee1c5c8d60cab8b8910e2f7f",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1740673800,
      "headline": "Viatris Inc. stock falls Thursday, underperforms market",
      "id": 132929367,
      "image": "",
      "related": "VTRS",
      "source": "MarketWatch",
      "summary": "Viatris Inc. stock falls Thursday, underperforms market",
      "url": "https://finnhub.io/api/news?id=6b578044d9a6ea461832329531e8c1452bae5835ee1c5c8d60cab8b8910e2f7f"
    }
  },
  {
    "ts": null,
    "headline": "Viatris plummets sharply on disappointing fourth-quarter, 2025 outlook",
    "summary": "Investing.com -- Shares in Viatris Inc (NASDAQ:VTRS) plummeted more than 17% following the market open on Thursday, after the company's Q4 results and guidance disappointed investors.",
    "url": "https://finnhub.io/api/news?id=14f26b5b8277f98f419abb321a0a0317e81506918b884cbb7486adc0042123bb",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1740672130,
      "headline": "Viatris plummets sharply on disappointing fourth-quarter, 2025 outlook",
      "id": 133193535,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "VTRS",
      "source": "Yahoo",
      "summary": "Investing.com -- Shares in Viatris Inc (NASDAQ:VTRS) plummeted more than 17% following the market open on Thursday, after the company's Q4 results and guidance disappointed investors.",
      "url": "https://finnhub.io/api/news?id=14f26b5b8277f98f419abb321a0a0317e81506918b884cbb7486adc0042123bb"
    }
  },
  {
    "ts": null,
    "headline": "Is Viatris Inc. (VTRS) the Best Low Price Pharma Stock to Invest In Right Now?",
    "summary": "We recently compiled a list of the 12 Best Low Price Pharma Stocks To Invest In Right Now. In this article, we are going to take a look at where Viatris Inc. (NASDAQ:VTRS) stands against the other pharma stocks. The Rising Demand for Weight-Loss Medications and GLP-1 Developments Healthcare, which includes numerous businesses that offer patient […]",
    "url": "https://finnhub.io/api/news?id=07751eaa2e7a814319c58cc735e21f4878efd355af7d38b9af7df45970576372",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1740664373,
      "headline": "Is Viatris Inc. (VTRS) the Best Low Price Pharma Stock to Invest In Right Now?",
      "id": 133193536,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "VTRS",
      "source": "Yahoo",
      "summary": "We recently compiled a list of the 12 Best Low Price Pharma Stocks To Invest In Right Now. In this article, we are going to take a look at where Viatris Inc. (NASDAQ:VTRS) stands against the other pharma stocks. The Rising Demand for Weight-Loss Medications and GLP-1 Developments Healthcare, which includes numerous businesses that offer patient […]",
      "url": "https://finnhub.io/api/news?id=07751eaa2e7a814319c58cc735e21f4878efd355af7d38b9af7df45970576372"
    }
  },
  {
    "ts": null,
    "headline": "Theravance's Q4 Loss In Line With Estimates, Sales Beat",
    "summary": "TBPH's fourth-quarter earnings match estimates while sales beat the same marginally. Increased collaboration revenues from Viatris drive revenues higher.",
    "url": "https://finnhub.io/api/news?id=1f2da9f6fb51b515efd8e4c43043db7f3fd54020e9e0bb85eb0df0d87d2d57f1",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1740663660,
      "headline": "Theravance's Q4 Loss In Line With Estimates, Sales Beat",
      "id": 133193537,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "VTRS",
      "source": "Yahoo",
      "summary": "TBPH's fourth-quarter earnings match estimates while sales beat the same marginally. Increased collaboration revenues from Viatris drive revenues higher.",
      "url": "https://finnhub.io/api/news?id=1f2da9f6fb51b515efd8e4c43043db7f3fd54020e9e0bb85eb0df0d87d2d57f1"
    }
  },
  {
    "ts": null,
    "headline": "Viatris Shares Decline After Earnings Miss, Lower 2025 Guidance",
    "summary": "Viatris forecasts $13.75 billion in revenue and $2.19 adjusted EPS, both below analyst expectations.",
    "url": "https://finnhub.io/api/news?id=04700df166e14a5732e1ae4f71ce3b7462b36ce91c0b11290742a96c1a40dc55",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1740663332,
      "headline": "Viatris Shares Decline After Earnings Miss, Lower 2025 Guidance",
      "id": 133193538,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "VTRS",
      "source": "Yahoo",
      "summary": "Viatris forecasts $13.75 billion in revenue and $2.19 adjusted EPS, both below analyst expectations.",
      "url": "https://finnhub.io/api/news?id=04700df166e14a5732e1ae4f71ce3b7462b36ce91c0b11290742a96c1a40dc55"
    }
  },
  {
    "ts": null,
    "headline": "Drugmaker Viatris forecasts weak 2025 results after import curbs on India plant",
    "summary": "(Reuters) -Viatris  forecast annual revenue and profit below Wall Street estimates on Thursday, mainly due to a worse-than-feared hit to sales from import restrictions on the drugmaker's manufacturing plant in India.  Shares of the Canonsburg, Pennsylvania-based Viatris fell about 17% to $9.34 in morning trade.  Viatris in December said the U.S. Food and Drug Administration (FDA) had restricted imports of 11 products from its facility in Indore, India due to violations found during an inspection.",
    "url": "https://finnhub.io/api/news?id=e73f4cb30a11bcc5d95156335c30617e876c67829f7e476e30ca1c214f2e12da",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1740662963,
      "headline": "Drugmaker Viatris forecasts weak 2025 results after import curbs on India plant",
      "id": 133193539,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "VTRS",
      "source": "Yahoo",
      "summary": "(Reuters) -Viatris  forecast annual revenue and profit below Wall Street estimates on Thursday, mainly due to a worse-than-feared hit to sales from import restrictions on the drugmaker's manufacturing plant in India.  Shares of the Canonsburg, Pennsylvania-based Viatris fell about 17% to $9.34 in morning trade.  Viatris in December said the U.S. Food and Drug Administration (FDA) had restricted imports of 11 products from its facility in Indore, India due to violations found during an inspection.",
      "url": "https://finnhub.io/api/news?id=e73f4cb30a11bcc5d95156335c30617e876c67829f7e476e30ca1c214f2e12da"
    }
  },
  {
    "ts": null,
    "headline": "Viatris Falls to 52-Week Low; FDA Import Alert for India Facility Weighs on Guidance",
    "summary": "Viatris Falls to 52-Week Low; FDA Import Alert for India Facility Weighs on Guidance",
    "url": "https://finnhub.io/api/news?id=0aa091da318e0eb204b0ea128970b97467320a3db49b4e97e21cadbc3579b27c",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1740662400,
      "headline": "Viatris Falls to 52-Week Low; FDA Import Alert for India Facility Weighs on Guidance",
      "id": 132929368,
      "image": "",
      "related": "VTRS",
      "source": "MarketWatch",
      "summary": "Viatris Falls to 52-Week Low; FDA Import Alert for India Facility Weighs on Guidance",
      "url": "https://finnhub.io/api/news?id=0aa091da318e0eb204b0ea128970b97467320a3db49b4e97e21cadbc3579b27c"
    }
  },
  {
    "ts": null,
    "headline": "Viatris (VTRS) Q4 Earnings and Revenues Lag Estimates",
    "summary": "Viatris (VTRS) delivered earnings and revenue surprises of -5.26% and 2.04%, respectively, for the quarter ended December 2024. Do the numbers hold clues to what lies ahead for the stock?",
    "url": "https://finnhub.io/api/news?id=a817d963c15cfcb7e14384942ebeb2663c3d45d5d23c4b4602a8cb2bccba0d45",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1740660906,
      "headline": "Viatris (VTRS) Q4 Earnings and Revenues Lag Estimates",
      "id": 133193540,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "VTRS",
      "source": "Yahoo",
      "summary": "Viatris (VTRS) delivered earnings and revenue surprises of -5.26% and 2.04%, respectively, for the quarter ended December 2024. Do the numbers hold clues to what lies ahead for the stock?",
      "url": "https://finnhub.io/api/news?id=a817d963c15cfcb7e14384942ebeb2663c3d45d5d23c4b4602a8cb2bccba0d45"
    }
  },
  {
    "ts": null,
    "headline": "Viatris Inc. (VTRS) Q4 2024 Earnings Call Transcript",
    "summary": "Viatris Inc. (NASDAQ:VTRS) Q4 2024 Earnings Conference Call February 27, 2025 8:30 AM ETCompany ParticipantsBill Szablewski - Head of Capital MarketsScott...",
    "url": "https://finnhub.io/api/news?id=945d6d2cba25e7f4f330b8a3622960d9eed0ec2e4cc9cf3f77b7a2f7210077e9",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1740657076,
      "headline": "Viatris Inc. (VTRS) Q4 2024 Earnings Call Transcript",
      "id": 132900443,
      "image": "https://static.seekingalpha.com/assets/og_image_1200-29b2bfe1a595477db6826bd2126c63ac2091efb7ec76347a8e7f81ba17e3de6c.png",
      "related": "VTRS",
      "source": "SeekingAlpha",
      "summary": "Viatris Inc. (NASDAQ:VTRS) Q4 2024 Earnings Conference Call February 27, 2025 8:30 AM ETCompany ParticipantsBill Szablewski - Head of Capital MarketsScott...",
      "url": "https://finnhub.io/api/news?id=945d6d2cba25e7f4f330b8a3622960d9eed0ec2e4cc9cf3f77b7a2f7210077e9"
    }
  },
  {
    "ts": null,
    "headline": "Viatris: One Swallow Doesn't Make A Summer",
    "summary": "Viatris Inc. missed sales/EPS estimates with 2025 guidance showing challenges like a $385M EBITDA hit. Learn why experts suggest avoiding VTRS stock.",
    "url": "https://finnhub.io/api/news?id=6b5939dc6536c9bfd675818b782116a0ad1ffd442b71de643c1c2367702a3502",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1740653561,
      "headline": "Viatris: One Swallow Doesn't Make A Summer",
      "id": 132900271,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/465389483/image_465389483.jpg?io=getty-c-w1536",
      "related": "VTRS",
      "source": "SeekingAlpha",
      "summary": "Viatris Inc. missed sales/EPS estimates with 2025 guidance showing challenges like a $385M EBITDA hit. Learn why experts suggest avoiding VTRS stock.",
      "url": "https://finnhub.io/api/news?id=6b5939dc6536c9bfd675818b782116a0ad1ffd442b71de643c1c2367702a3502"
    }
  },
  {
    "ts": null,
    "headline": "Viatris Inc. 2024 Q4 - Results - Earnings Call Presentation",
    "summary": "The following slide deck was published by Viatris Inc.",
    "url": "https://finnhub.io/api/news?id=c247d79f7baf4ff78aee6e215793be6610a6cb0a1e8611793a9ddaecee7e8079",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1740646148,
      "headline": "Viatris Inc. 2024 Q4 - Results - Earnings Call Presentation",
      "id": 132899832,
      "image": "https://static.seekingalpha.com/assets/og_image_1200-29b2bfe1a595477db6826bd2126c63ac2091efb7ec76347a8e7f81ba17e3de6c.png",
      "related": "VTRS",
      "source": "SeekingAlpha",
      "summary": "The following slide deck was published by Viatris Inc.",
      "url": "https://finnhub.io/api/news?id=c247d79f7baf4ff78aee6e215793be6610a6cb0a1e8611793a9ddaecee7e8079"
    }
  },
  {
    "ts": null,
    "headline": "Viatris : VTRS Q4 2024 Earnings Infographic - FINAL",
    "summary": "Full Year 2024 Financial Results Total Revenues ...",
    "url": "https://finnhub.io/api/news?id=2d9ab4f37d947a408bf34f210a5f68f2242b77f4b863ead083bc8bbc789d0dcd",
    "source": "Finnhub",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1740640691,
      "headline": "Viatris : VTRS Q4 2024 Earnings Infographic - FINAL",
      "id": 132899246,
      "image": "",
      "related": "VTRS",
      "source": "Finnhub",
      "summary": "Full Year 2024 Financial Results Total Revenues ...",
      "url": "https://finnhub.io/api/news?id=2d9ab4f37d947a408bf34f210a5f68f2242b77f4b863ead083bc8bbc789d0dcd"
    }
  },
  {
    "ts": null,
    "headline": "Viatris : VTRS Q4 2024 Earnings Presentation - FINAL",
    "summary": "Q4 & Full Year 2024 Earnings February 27, 2025 Non-GAAP Financial Measures and Other Information ...",
    "url": "https://finnhub.io/api/news?id=20ada5e5f2391a462c148db73f20e2b0be2c060ceb21f32de942b31faba14055",
    "source": "Finnhub",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1740640691,
      "headline": "Viatris : VTRS Q4 2024 Earnings Presentation - FINAL",
      "id": 132899245,
      "image": "",
      "related": "VTRS",
      "source": "Finnhub",
      "summary": "Q4 & Full Year 2024 Earnings February 27, 2025 Non-GAAP Financial Measures and Other Information ...",
      "url": "https://finnhub.io/api/news?id=20ada5e5f2391a462c148db73f20e2b0be2c060ceb21f32de942b31faba14055"
    }
  },
  {
    "ts": null,
    "headline": "Viatris Merger Notification Violation In Morocco",
    "summary": "In November 2024, the Moroccan Competition Council imposed a fine of MAD 7.58 million dirhams on Viatris Inc., a US based pharmaceutical company, for failing to notify the merger that formed it. The...",
    "url": "https://finnhub.io/api/news?id=ba9272748995a192d3818f9d07afa824551c5322d46013043f0773db4f025efb",
    "source": "Finnhub",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1740640211,
      "headline": "Viatris Merger Notification Violation In Morocco",
      "id": 132899212,
      "image": "",
      "related": "VTRS",
      "source": "Finnhub",
      "summary": "In November 2024, the Moroccan Competition Council imposed a fine of MAD 7.58 million dirhams on Viatris Inc., a US based pharmaceutical company, for failing to notify the merger that formed it. The...",
      "url": "https://finnhub.io/api/news?id=ba9272748995a192d3818f9d07afa824551c5322d46013043f0773db4f025efb"
    }
  },
  {
    "ts": null,
    "headline": "Viatris: Q4 Earnings Snapshot",
    "summary": "CANONSBURG, Pa. — CANONSBURG, Pa. — Viatris Inc on Thursday reported a loss of $516.5 million in its fourth quarter. The Canonsburg, Pennsylvania-based company said it had a loss of 43 cents...",
    "url": "https://finnhub.io/api/news?id=00d0b4cbd5a9491c8aa57d347481fd125767547aeebc5be76dda724968dd9769",
    "source": "Finnhub",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1740639850,
      "headline": "Viatris: Q4 Earnings Snapshot",
      "id": 132899088,
      "image": "",
      "related": "VTRS",
      "source": "Finnhub",
      "summary": "CANONSBURG, Pa. — CANONSBURG, Pa. — Viatris Inc on Thursday reported a loss of $516.5 million in its fourth quarter. The Canonsburg, Pennsylvania-based company said it had a loss of 43 cents...",
      "url": "https://finnhub.io/api/news?id=00d0b4cbd5a9491c8aa57d347481fd125767547aeebc5be76dda724968dd9769"
    }
  },
  {
    "ts": null,
    "headline": "Viatris Reports Fourth Quarter and Full Year 2024 Financial Results and Provides 2025 Financial Guidance",
    "summary": "PITTSBURGH, Feb. 27, 2025 /PRNewswire/ --  Meets 2024 Guidance for Total Revenues, Adjusted EBITDA and Adjusted EPS; Exceeds 2024 Guidance for Free Cash Flow...",
    "url": "https://finnhub.io/api/news?id=4e49cc730f2a1d552ce986543bb14602dcaf515c1d1b882e8c435e0173e3e897",
    "source": "Finnhub",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1740638770,
      "headline": "Viatris Reports Fourth Quarter and Full Year 2024 Financial Results and Provides 2025 Financial Guidance",
      "id": 132898977,
      "image": "",
      "related": "VTRS",
      "source": "Finnhub",
      "summary": "PITTSBURGH, Feb. 27, 2025 /PRNewswire/ --  Meets 2024 Guidance for Total Revenues, Adjusted EBITDA and Adjusted EPS; Exceeds 2024 Guidance for Free Cash Flow...",
      "url": "https://finnhub.io/api/news?id=4e49cc730f2a1d552ce986543bb14602dcaf515c1d1b882e8c435e0173e3e897"
    }
  },
  {
    "ts": null,
    "headline": "Viatris Maintains Dividend Policy for 2025 and Announces Quarterly Dividend",
    "summary": "PITTSBURGH, Feb. 27, 2025 /PRNewswire/ -- Viatris Inc. today announced that on February 24, 2025, its Board of Directors approved a 2025 dividend policy of 48 cents  per share and declared a...",
    "url": "https://finnhub.io/api/news?id=03acf9d481225d8e6d8d4dbf10135ac0eec4bb668f62b3fd57463eeddd41a7bd",
    "source": "Finnhub",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1740637871,
      "headline": "Viatris Maintains Dividend Policy for 2025 and Announces Quarterly Dividend",
      "id": 132898874,
      "image": "",
      "related": "VTRS",
      "source": "Finnhub",
      "summary": "PITTSBURGH, Feb. 27, 2025 /PRNewswire/ -- Viatris Inc. today announced that on February 24, 2025, its Board of Directors approved a 2025 dividend policy of 48 cents  per share and declared a...",
      "url": "https://finnhub.io/api/news?id=03acf9d481225d8e6d8d4dbf10135ac0eec4bb668f62b3fd57463eeddd41a7bd"
    }
  },
  {
    "ts": null,
    "headline": "Dell Technologies headlines earnings slate",
    "summary": "Dell Technologies headlines earnings slate",
    "url": "https://finnhub.io/api/news?id=ac1211ee0c46dcee80de249f168f17ffb4551a4b5b7ee28671bc6f7bc6161c60",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1740635331,
      "headline": "Dell Technologies headlines earnings slate",
      "id": 132915322,
      "image": "",
      "related": "VTRS",
      "source": "MarketWatch",
      "summary": "Dell Technologies headlines earnings slate",
      "url": "https://finnhub.io/api/news?id=ac1211ee0c46dcee80de249f168f17ffb4551a4b5b7ee28671bc6f7bc6161c60"
    }
  }
]